4,5-Difluoro-3-hydroxyisobenzofuran-1(3H)-one

Catalog No. :
ACMGPX503
CAS No. :
2136287-63-1
Molecular Formula :
C8H4F2O3
Molecular Weight :
186.11

IUPAC Name:4,5-difluoro-3-hydroxyisobenzofuran-1(3H)-one

4,5-Difluoro-3-hydroxyisobenzofuran-1(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$149.00Login to see priceIn stockIn stock
250mg95%$251.00Login to see priceIn stockIn stock
1g95%$727.00Login to see priceIn stockInquiry
5g95%$3478.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5-Difluoro-3-hydroxyisobenzofuran-1(3H)-one
IUPAC Name4,5-difluoro-3-hydroxyisobenzofuran-1(3H)-one
MDL No.MFCD34179630
Molecular FormulaC8H4F2O3
Molecular Weight186.11
SMILESO=C1OC(O)C2=C1C=CC(F)=C2F
InChI KeyUOYAGLRGMZBIKY-UHFFFAOYSA-N
Synonym1(3H)-Isobenzofuranone, 4,5-difluoro-3-hydroxy-;4,5-difluoro-3-hydroxyisobenzofuran-1(3H)-oneQ: What is 4,5-difluoro-3-hydroxyisobenzofuran-1(3H)-one Q: What is the CAS Number of 4,5-difluoro-3-hydroxyisobenzofuran-1(3H)-one;4,5-Difluoro-3-hydroxyisobenzofuran-1(3H)-one;*Buprenorphine Impurity 11;SM1-04(559-3)
CAS No.2136287-63-1
PubChem CID132820277

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMGPX503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGPX503 route product structure diagram
    ACMGPX5032136287-63-1 In Stock
Inquiry

2. ACMGPX503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGPX503 route product structure diagram
    ACMGPX5032136287-63-1 In Stock
Inquiry

Comments (0)